Clinical Trial Update: Effect of Ezetimibe on Gut Microbiota [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of ezetimibe on gut microbiota in patients with atherosclerotic cardiovascular disease and dyslipidemia; currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Dyslipidemia

Drugs mentioned

• Zetia (ezetimibe)

Snippet

Sponsor: Yonsei University | Conditions: Atherosclerotic Cardiovascular Disease With Dyslipidemia | Phase 4 | Status: RECRUITING